207 related articles for article (PubMed ID: 33843213)
1. Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target.
Giatti S; Di Domizio A; Diviccaro S; Falvo E; Caruso D; Contini A; Melcangi RC
J Med Chem; 2021 Apr; 64(8):4553-4566. PubMed ID: 33843213
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
Yao Z; Xu Y; Zhang M; Jiang S; Nicklaus MC; Liao C
Bioorg Med Chem Lett; 2011 Jan; 21(1):475-8. PubMed ID: 21094046
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and bioactivity of new Finasteride conjugate.
Shuang Z; Jiazhen W; Lijuan Y; Zhuo L; Dahai Y; Jinfeng L; Jing Y; Yongtao L; En-Si W; Xuexun F
Bioorg Med Chem Lett; 2011 Jun; 21(11):3439-42. PubMed ID: 21515045
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
[TBL] [Abstract][Full Text] [Related]
6. CGP 53153: a new potent inhibitor of 5alpha-reductase.
Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
[TBL] [Abstract][Full Text] [Related]
7. Quintaquinone, a Merosesquiterpene from the Yellow Sponge
Jiso A; Kittiwisut S; Chantakul R; Yuenyongsawad S; Putchakarn S; Schäberle TF; Temkitthaworn P; Ingkaninan K; Chaithirayanon K; Plubrukarn A
J Nat Prod; 2020 Feb; 83(2):532-536. PubMed ID: 32040314
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor.
Grunewald GL; Dahanukar VH; Jalluri RK; Criscione KR
J Med Chem; 1999 Jan; 42(1):118-34. PubMed ID: 9888838
[TBL] [Abstract][Full Text] [Related]
9. In vivo investigation in pigs of intestinal absorption, hepatobiliary disposition, and metabolism of the 5α-reductase inhibitor finasteride and the effects of coadministered ketoconazole.
Lundahl A; Hedeland M; Bondesson U; Lennernäs H
Drug Metab Dispos; 2011 May; 39(5):847-57. PubMed ID: 21317368
[TBL] [Abstract][Full Text] [Related]
10. Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens.
Soggiu A; Piras C; Greco V; Devoto P; Urbani A; Calzetta L; Bortolato M; Roncada P
Psychoneuroendocrinology; 2016 Dec; 74():387-396. PubMed ID: 27750143
[TBL] [Abstract][Full Text] [Related]
11. Studies on the distribution of phenylethanolamine N-methyltransferase and epinephrine in the rat.
Pendleton RG; Gessner G; Sawyer J
Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):315-25. PubMed ID: 694228
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition.
Azzolina B; Ellsworth K; Andersson S; Geissler W; Bull HG; Harris GS
J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):55-64. PubMed ID: 9328210
[TBL] [Abstract][Full Text] [Related]
13. Repeated finasteride administration induces depression-like behavior in adult male rats.
Sasibhushana RB; Shankaranarayana Rao BS; Srikumar BN
Behav Brain Res; 2019 Jun; 365():185-189. PubMed ID: 30836157
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
15. Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors.
Drinkwater N; Vu H; Lovell KM; Criscione KR; Collins BM; Prisinzano TE; Poulsen SA; McLeish MJ; Grunewald GL; Martin JL
Biochem J; 2010 Oct; 431(1):51-61. PubMed ID: 20642456
[TBL] [Abstract][Full Text] [Related]
16. Effects of the anti-androgen finasteride on 5alpha-reductase activity in human gingival fibroblasts in response to minocycline.
Soory M; Virdi H
J Clin Periodontol; 1998 Jan; 25(1):67-73. PubMed ID: 9477022
[TBL] [Abstract][Full Text] [Related]
17. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor.
di Salle E; Giudici D; Radice A; Zaccheo T; Ornati G; Nesi M; Panzeri A; Délos S; Martin PM
J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412
[TBL] [Abstract][Full Text] [Related]
18. Stressor specificity and effect of prior experience on catecholamine biosynthetic enzyme phenylethanolamine N-methyltransferase.
Kvetnansky R
Ann N Y Acad Sci; 2004 Dec; 1032():117-29. PubMed ID: 15677399
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of an immobilized phenylethanolamine N-methyltransferase liquid chromatographic stationary phase.
Markoglou N; Wainer IW
Anal Biochem; 2001 Jan; 288(1):83-8. PubMed ID: 11141309
[TBL] [Abstract][Full Text] [Related]
20. Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage-Animal, Experimental Study.
Baig MS; Kolasa-Wołosiuk A; Pilutin A; Safranow K; Baranowska-Bosiacka I; Kabat-Koperska J; Wiszniewska B
Int J Environ Res Public Health; 2019 May; 16(10):. PubMed ID: 31100850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
